Earnings Call · Q2 FY2024·2024-08-01

Q2 24EPS +8.85%·Rev n/aQ1 24EPS -5.45%·Rev n/aQ4 23EPS +10.33%·Rev n/aQ3 23EPS +7.51%·Rev n/a⚠ consensus missing

REGENERON PHARMACEUTICALS, INC. REGN

+1.3%1d on move date+2.7% vs SPY3d−0.7%5d−1.1%

Research tier

Behavioral profile computed for this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more REGN calls or request research access.

More REGN calls Browse calls Request research access